These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9291160)

  • 1. Treatment of inflammatory neuropathy.
    Hughes RA; Gabriel CM; Gregson NA; Smith KJ
    Mult Scler; 1997 Apr; 3(2):88-92. PubMed ID: 9291160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA; Allen D; Makowska A; Gregson NA
    J Peripher Nerv Syst; 2006 Mar; 11(1):30-46. PubMed ID: 16519780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory neuropathies.
    Hughes RA
    Baillieres Clin Neurol; 1994 Apr; 3(1):45-72. PubMed ID: 7921591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurophysiological changes in demyelinating and axonal forms of acute experimental autoimmune neuritis in the Lewis rat.
    Taylor JM; Pollard JD
    Muscle Nerve; 2003 Sep; 28(3):344-52. PubMed ID: 12929195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis in long-term immunosuppressive treatment of refractory chronic inflammatory demyelinating polyradiculoneuropathy.
    Bromberg MB; Feldman EL; Jaradeh S; Albers JW
    J Clin Epidemiol; 1992 Jan; 45(1):47-52. PubMed ID: 1738011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1.
    Archelos JJ; Mäurer M; Jung S; Miyasaka M; Tamatani T; Toyka KV; Hartung HP
    Lab Invest; 1994 May; 70(5):667-75. PubMed ID: 8196363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane attack complex of complement is not essential for immune mediated demyelination in experimental autoimmune neuritis.
    Tran GT; Hodgkinson SJ; Carter NM; Killingsworth M; Nomura M; Verma ND; Plain KM; Boyd R; Hall BM
    J Neuroimmunol; 2010 Dec; 229(1-2):98-106. PubMed ID: 20850187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immunity in inflammatory autoimmune neuropathies.
    Mäurer M; Toyka KV; Gold R
    Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S7-15. PubMed ID: 12690655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic inflammatory demyelinating polyradiculoneuropathy.
    Pollard JD
    Baillieres Clin Neurol; 1994 Apr; 3(1):107-27. PubMed ID: 7921585
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental allergic neuritis (EAN) as a model for the immune-mediated demyelinating neuropathies.
    Hahn AF
    Rev Neurol (Paris); 1996 May; 152(5):328-32. PubMed ID: 8881424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic inflammatory demyelinating polyradiculoneuropathy.
    Mendell JR
    Annu Rev Med; 1993; 44():211-9. PubMed ID: 8476243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of intravenous immunoglobulin (IVIg) therapy in experimental autoimmune neuritis (EAN) of the Lewis rat.
    Enders U; Toyka KV; Hartung HP; Gold R
    J Neuroimmunol; 1997 Jun; 76(1-2):112-6. PubMed ID: 9184640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of Foxp3(+) T-regulatory cells in experimental autoimmune neuritis rats.
    Zhang Z; Zhang ZY; Fauser U; Schluesener HJ
    Exp Neurol; 2009 Mar; 216(1):75-82. PubMed ID: 19100737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of myasthenia gravis in childhood associated with chronic inflammatory demyelinating polyradiculoneuropathy.
    Kimura K; Nezu A; Kimura S; Otsuki N; Kobayashi T; Nomura Y; Segawa M
    Neuropediatrics; 1998 Apr; 29(2):108-12. PubMed ID: 9638666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Demyelination and autoimmunity].
    Lebar R
    Pathol Biol (Paris); 1987 Mar; 35(3):275-83. PubMed ID: 3295694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin preparation attenuates neurological signs in rat experimental autoimmune neuritis with the suppression of macrophage inflammatory protein -1α expression.
    Kajii M; Kobayashi F; Kashihara J; Yuuki T; Kubo Y; Nakae T; Kamizono A; Kuzumoto Y; Kusunoki S
    J Neuroimmunol; 2014 Jan; 266(1-2):43-8. PubMed ID: 24262701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological studies of Guillain-Barré syndrome with different susceptibilities to develop EAN serum on 2 strains of rats.
    Low PA; Schmelzer J; Dyck PJ; Kelly JJ
    Electroencephalogr Clin Neurophysiol Suppl; 1982; 36():81-90. PubMed ID: 6984386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune reactions to P2 protein in human inflammatory demyelinative neuropathies.
    Zweiman B; Rostami A; Lisak RP; Moskovitz AR; Pleasure DE
    Neurology; 1983 Feb; 33(2):234-7. PubMed ID: 6600513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demyelinating inflammatory neuropathies, including Guillain-Barré syndrome.
    Steck AJ; Schaeren-Wiemers N; Hartung HP
    Curr Opin Neurol; 1998 Aug; 11(4):311-8. PubMed ID: 9725076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.